Methylated CpG polynucleotide
US7871984B2 · kind B2 · utility
1Cited by
3References
4Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 23, 2004 |
| Grant date | Jan 18, 2011 |
| Priority date | — |
| Expiry date | Sep 17, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/336
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
It is an object of the present invention to provide a polynucleotide, which can effectively suppress the immunoreactivity caused by DNA having a CpG motif and which can be used for preventing and/or treating immune-mediated diseases such as arthritis. The present invention provides a polynucleotide comprising a CpG motif wherein guanine is methylated, and a pharmaceutical composition comprising the above-mentioned polynucleotide.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.